4.7 Review

N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 167, 期 -, 页码 -

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2023.115477

关键词

Cancer; N6-methyladenosine; RNA metabolism; Therapeutic resistance; Epigenetics

向作者/读者索取更多资源

Cancer therapy resistance (CTR) severely affects clinical response and recent studies have shown that N6methyladenosine (m6A) modifications play a critical role in reversing CTR. This review summarizes the potential molecular mechanisms of m6A modification in CTR and discusses the recent advances in natural products and small-molecule lead compounds targeting m6A modifications.
Cancer therapy resistance (CTR) is the development of cancer resistance to multiple therapeutic strategies, which severely affects clinical response and leads to cancer progression, recurrence, and metastasis. N6methyladenosine (m6A) has been identified as the most common, abundant, and conserved internal transcriptional alterations of RNA modifications, regulating RNA splicing, translation, stabilization, degradation, and gene expression, and is involved in the development and progression of a variety of diseases, including cancer. Recent studies have shown that m6A modifications play a critical role in both cancer development and progression, especially in reversing CTR. Although m6A modifications have great potential in CTR, the specific molecular mechanisms are not fully elucidated. In this review, we summarize the potential molecular mechanisms of m6A modification in CTR. In addition, we update recent advances in natural products from Traditional Chinese Medicines (TCM) and small-molecule lead compounds targeting m6A modifications, and discuss the great potential and clinical implications of these inhibitors targeting m6A regulators and combinations with other therapies to improve clinical efficacy and overcome CTR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据